<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Herhaus L</submitter><funding>Medical Research Council</funding><pagination>140065</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4042855</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4(5)</volume><pubmed_abstract>Protein kinase ALK3/BMPR1A mediates bone morphogenetic protein (BMP) signalling through phosphorylation and activation of SMADs 1/5/8. SMAD6, a transcriptional target of BMP, negatively regulates the BMP pathway by recruiting E3 ubiquitin ligases and targeting ALK3 for ubiquitin-mediated degradation. Here, we identify a deubiquitylating enzyme USP15 as an interactor of SMAD6 and ALK3. We show that USP15 enhances BMP-induced phosphorylation of SMAD1 by interacting with and deubiquitylating ALK3. RNAi-mediated depletion of USP15 increases ALK3 K48-linked polyubiquitylation, and reduces both BMP-induced SMAD1 phosphorylation and transcription of BMP target genes. We also show that loss of USP15 expression from mouse myoblast cells inhibits BMP-induced osteoblast differentiation. Furthermore, </pubmed_abstract><journal>Open biology</journal><pubmed_title>USP15 targets ALK3/BMPR1A for deubiquitylation to enhance bone morphogenetic protein signalling.</pubmed_title><pmcid>PMC4042855</pmcid><funding_grant_id>U117597140</funding_grant_id><funding_grant_id>MC_U127092717</funding_grant_id><funding_grant_id>MC_U117597140</funding_grant_id><funding_grant_id>MC_UU_12016/3</funding_grant_id><pubmed_authors>Cummins TD</pubmed_authors><pubmed_authors>Sapkota GP</pubmed_authors><pubmed_authors>Wasmus L</pubmed_authors><pubmed_authors>Ewan R</pubmed_authors><pubmed_authors>Bruce D</pubmed_authors><pubmed_authors>Herhaus L</pubmed_authors><pubmed_authors>Vogt J</pubmed_authors><pubmed_authors>Al-Salihi MA</pubmed_authors><pubmed_authors>Dingwell KS</pubmed_authors><pubmed_authors>Macartney T</pubmed_authors><pubmed_authors>Smith JC</pubmed_authors><pubmed_authors>Weidlich S</pubmed_authors></additional><is_claimable>false</is_claimable><name>USP15 targets ALK3/BMPR1A for deubiquitylation to enhance bone morphogenetic protein signalling.</name><description>Protein kinase ALK3/BMPR1A mediates bone morphogenetic protein (BMP) signalling through phosphorylation and activation of SMADs 1/5/8. SMAD6, a transcriptional target of BMP, negatively regulates the BMP pathway by recruiting E3 ubiquitin ligases and targeting ALK3 for ubiquitin-mediated degradation. Here, we identify a deubiquitylating enzyme USP15 as an interactor of SMAD6 and ALK3. We show that USP15 enhances BMP-induced phosphorylation of SMAD1 by interacting with and deubiquitylating ALK3. RNAi-mediated depletion of USP15 increases ALK3 K48-linked polyubiquitylation, and reduces both BMP-induced SMAD1 phosphorylation and transcription of BMP target genes. We also show that loss of USP15 expression from mouse myoblast cells inhibits BMP-induced osteoblast differentiation. Furthermore, </description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 May</publication><modification>2025-04-21T20:06:07.671Z</modification><creation>2019-03-27T01:29:22Z</creation></dates><accession>S-EPMC4042855</accession><cross_references><pubmed>24850914</pubmed><doi>10.1098/rsob.140065</doi></cross_references></HashMap>